GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Pfizer Ltd

Pfizer Ltd: CFO Amit Agarwal Resigns Effective October 8, 2026

MANAGEMENT ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 27 Jul 2026, 04:32 PM IST  ·  BSE ID: d7080eb7-5622-4ab9-a338-0d0fb4dea5c8
View Original BSE Filing (PDF)
💡
In Simple Terms
Pfizer Ltd's Chief Financial Officer, Amit Agarwal, is leaving the company on October 8, 2026, to take a job elsewhere.
🤖 AI Summary
  • Amit Agarwal resigns as Executive Director - Finance & CFO of Pfizer Ltd.
  • Resignation is effective October 8, 2026, to pursue external opportunities.
  • Mr. Agarwal will also cease board and committee memberships on this date.
  • Disclosure made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements.
🏢 How This Affects the Company
⚙️
Operational Impact
The departure of the CFO will necessitate a transition in financial leadership and oversight of the company's financial strategy and reporting.
⚠️
Risk Impact
A change in key financial leadership introduces a period of transition risk, requiring the company to ensure continuity in financial management and reporting.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this resignation.
👤
Who Is Affected
Shareholders are indirectly affected by potential shifts in financial strategy and leadership continuity.
🔍
Management Signal
The resignation signals Mr. Agarwal's intent to leave Pfizer Limited for new professional challenges.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of new CFO appointment by October 8, 2026.
Follow-up disclosures on committee memberships post-transition.
Q3 FY27 results announcement to assess financial performance continuity.
MEDIUM RISK Departure of CFO creates uncertainty in financial leadership and strategic direction.
💡 Investor Takeaway
Pfizer Ltd's CFO, Amit Agarwal, resigns effective October 8, 2026. He will also step down from board and committee roles, signaling a change in financial leadership.
❓ Frequently Asked Questions
Who is resigning from Pfizer Ltd?
Mr. Amit Agarwal, Executive Director – Finance & Chief Financial Officer, is resigning from Pfizer Ltd.
When is Amit Agarwal's resignation effective?
Mr. Amit Agarwal's resignation is effective October 8, 2026.
What other roles will Amit Agarwal vacate?
Mr. Agarwal will also cease to be a Director on the Board and a Member of the CSR, Risk Management, and Board Administrative Committees.
Why is Amit Agarwal leaving Pfizer Ltd?
Mr. Agarwal is resigning to pursue an opportunity outside Pfizer Limited.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.